Pranay Khare

Pranay Khare

Company: Genocea

Job title: Director, Cell Therapy Development & Manufacturing


Solid Tumor Targeting with GEN-011: An Autologous Multi- Neoantigens-Specific Peripheral-Blood Derived T Cell Therapy 4:00 pm

• Importance of tumor-specific neoantigen selection with ATLASTM bioassay for cancer immunotherapies • Discuss the plan for a robust, scalable, reproducible and closed “PLANET” manufacturing process • GEN-011 is an autologous, multi-neoantigen-specific T cell therapy with memory T cells phenotype and harboring self-renewing, stem-like characteristicsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.